Effect of secondhand cigarette smoke, RSV bronchiolitis and parental asthma on urinary cysteinyl LTE4

Pediatric Pulmonology

Volumn 43, Issue 8, 2008, Pages 760-766

  Kott, Kayleen S ^a   Salt, Bryn H ^b   McDonald, Ruth J ^a   Jhawar, Sanjay ^a   Brie, John M ^a   Joad, Jesse P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

Cotinine; Cysteinyl leukotrienes; Infants; Parental asthma; Respiratory syncytial virus; Secondhand cigarette smoke

Indexed keywords

CIGARETTE SMOKE; COTININE; CREATININE; CYSTEINYL LEUKOTRIENE E4; PEPTIDOLEUKOTRIENE;

ANALYSIS OF VARIANCE; ARTICLE; ASTHMA; BRONCHIOLITIS; CHI SQUARE TEST; CONTROLLED STUDY; CREATININE URINE LEVEL; DISEASE SEVERITY; FEMALE; HOSPITALIZATION; HUMAN; INFANT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PASSIVE SMOKING; PRIORITY JOURNAL; STUDENT T TEST; URINALYSIS; VIRUS INFECTION;

ASTHMA; BRONCHIOLITIS, VIRAL; COTININE; CREATININE; CYSTEINE; FEMALE; HUMANS; INFANT; LENGTH OF STAY; LEUKOTRIENES; MALE; RESPIRATORY SYNCYTIAL VIRUSES; SEVERITY OF ILLNESS INDEX; SMOKING;

EID: 49649083078     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.20853     Document Type: Article

References (38)

1. Joad JP. Smoking and pediatric respiratory health. Clin Chest Med 2000;21:37-46. vii-viii.
2. Landau LI. Parental smoking: asthma and wheezing illnesses in infants and children. Paediatr Respir Rev 2001;2:202-206.
3. OEHHA. Health Effects of Exposure to Environmental Tobacco Smoke. Oakland, CA: Office of Environmental Health Hazard Assessment, California Environmental Protection Agency; 1997.
4. U.S. EPA Washington D. Respiratory Health Effects of Passive Smoking: Lung Cancer and Other Disorders. EPA/600/6-90/006F. Washington, DC: Office of Research and Development, U.S. Environmental Protection Agency; 1992.
5. U.S. DHHS Washington D. The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating; Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2006.
6. Strachan DP, Cook DG. Health effects of passive smoking. 1. Parental smoking and lower respiratory illness in infancy and early childhood. Thorax 1997;52:905-914.
7. Stein RT, Sherrill D, Morgan WJ, Holberg CJ, Halonen M, Taussig LM, Wright AL, Martinez FD. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999;354:541-545.
8. Busse WW. Leukotrienes and inflammation. Am J Respir Crit Care Med 1998;157:S210-S213.
9. Piedimonte G, Renzetti G, Auais A, Di Marco A, Tripodi S, Colistro F, Villani A, Di Ciommo V, Cutrera R. Leukotriene synthesis during respiratory syncytial virus bronchiolitis: influence of age and atopy. Pediatr Pulmonol 2005;40:285-291.
10. Takahashi Y, Ichikawa M, Nawate M, Kamoshida H, Shikano T. Clinical evaluation of urinary leukotriene e4 levels in children with respiratory syncytial virus infection. Arerugi 2003;52:1132-1137.
11. Fauler J, Frolich JC. Cigarette smoking stimulates cysteinyl leukotriene production in man. Eur J Clin Invest 1997;27:43-47.
12. Green SA, Malice MP, Tanaka W, Tozzi CA, Reiss TF. Increase in urinary leukotriene LTE4 levels in acute asthma: correlation with airflow limitation. Thorax 2004;59:100-104.
13. Severien C, Artlich A, Jonas S, Becher G. Urinary excretion of leukotriene E4 and eosinophil protein X in children with atopic asthma. Eur Respir J 2000;16:588-592.
14. Bjerg A, Hedman L, Perzanowski MS, Platts-Mills T, Lundback B, Ronmark E. Family history of asthma and atopy: in-depth analyses of the impact on asthma and wheeze in 7- to 8-year-old children. Pediatrics 2007;120:741-748.
15. Arshad SH, Kurukulaaratchy RJ, Fenn M, Matthews S. Early life risk factors for current wheeze, asthma, and bronchial hyperresponsiveness at 10 years of age. Chest 2005;127:502-508.
16. Lemanske RF, Jr. Issues in understanding pediatric asthma: epidemiology and genetics. J Allergy Clin Immunol 2002;109:S521-S524.
17. Bernert JT, Jr., Turner WE, Pirkle JL, Sosnoff CS, Akins JR, Waldrep MK, Ann Q, Covey TR, Whitfield WE, Gunter EW, Miller BB, Patterson DG, Jr., Needham LL, Hannon WH, Sampson EJ. Development and validation of sensitive method for determination of serum cotinine in smokers and nonsmokers by liquid chromatography/atmospheric pressure ionization tandem mass spectrometry. Clin Chem 1997;43:2281-2291.
18. Dempsey D, Jacob P III, Benowitz NL. Nicotine metabolism and elimination kinetics in newborns. Clin Pharmacol Ther 2000;67:458-465.
19. Saareks V, Riutta A, Alanko J, Ylitalo P, Parviainen M, Mucha I, Sievi E, Vapaatalo H. Clinical pharmacology of eicosanoids, nicotine induced changes in man. J Physiol Pharmacol 2000;51:631-642.
20. van Schaik SM, Welliver RC, Kimpen JL. Novel pathways in the pathogenesis of respiratory syncytial virus disease. Pediatr Pulmonol 2000;30:131-138.
21. Sznajer Y, Westcott JY, Wenzel SE, Mazer B, Tucci M, Toledano BJ. Airway eicosanoids in acute severe respiratory syncytial virus bronchiolitis. J Pediatr 2004;145:115-118.
22. van Schaik SM, Tristram DA, Nagpal IS, Hintz KM, Welliver RC II, Welliver RC. Increased production of IFN-gamma and cysteinyl leukotrienes in virus-induced wheezing. J Allergy Clin Immunol 1999;103:630-636.
23. Kim CK, Koh JY, Han TH, Kim do K, Kim BI, Koh YY. Increased levels of BAL cysteinyl leukotrienes in acute RSV bronchiolitis. Acta Paediatr 2006;95:479-485.
24. Bradley JP, Bacharier LB, Bonfiglio J, Schechtman KB, Strunk R, Storch G, Castro M. Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy. Pediatrics 2005;115:e7-e14.
25. Gurkan F, Kiral A, Dagli E, Karakoc F. The effect of passive smoking on the development of respiratory syncytial virus bronchiolitis. Eur J Epidemiol 2000;16:465-468.
26. Reese AC, James IR, Landau LI, Lesouef PN. Relationship between urinary cotinine level and diagnosis in children admitted to hospital. Am Rev Respir Dis 1992;146:66-70.
27. Da Dalt L, Callegaro S, Carraro S, Andreola B, Corradi M, Baraldi E. Nasal lavage leukotrienes in infants with RSV bronchiolitis. Pediatr Allergy Immunol 2007;18:100-104.
28. Henderson FW, Reid HF, Morris R, Wang OL, Hu PC, Helms RW, Forehand L, Mumford J, Lewtas J, Haley NJ, Hammond SK. Home air nicotine levels and urinary cotinine excretion in preschool children. Am Rev Respir Dis 1989;140:197-201.
29. Ownby DR, Johnson CC, Peterson EL. Passive cigarette smoke exposure of infants: importance of nonparental sources. Arch Pediatr Adolesc Med 2000;154:1237-1241.
30. Matt GE, Quintana PJ, Hovell MF, Bernert JT, Song S, Novianti N, Juarez T, Floro J, Gehrman C, Garcia M, Larson S. Households contaminated by environmental tobacco smoke: sources of infant exposures. Tob Control 2004;13:29-37.
31. Belanger K, Beckett W, Triche E, Bracken MB, Holford T, Ren P, McSharry JE, Gold DR, Platts-Mills TA, Leaderer BP. Symptoms of wheeze and persistent cough in the first year of life: associations with indoor allergens, air contaminants, and maternal history of asthma. Am J Epidemiol 2003;158:195-202.
32. Lannero E, Wickman M, van Hage M, Bergstrom A, Pershagen G, Nordvall L. Exposure to environmental tobacco smoke and sensitisation in children. Thorax 2008;63:172-176.
33. Bisgaard H. A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis. Am J Respir Crit Care Med 2003;167:379-383.
34. Ehrlich RI, Du Toit D, Jordaan E, Zwarenstein M, Potter P, Volmink JA, Weinberg E. Risk factors for childhood asthma and wheezing. Importance of maternal and household smoking. Am J Respir Crit Care Med 1996;154:681-688.
35. Campbell PW III, Parker RA, Roberts BT, Krishnamani MR, Phillips JA III. Association of poor clinical status and heavy exposure to tobacco smoke in patients with cystic fibrosis who are homozygous for the F508 deletion. J Pediatr 1992;120:261-264.
36. Inoue R, Fukao T, Kato Y, Teramoto T, Utsumi M, Kondo N. Time-course study of the levels of urinary leukotriene E4, serum thromboxane B2 and serum eosinophil cationic protein in spontaneous asthma attacks in five children. J Investig Allergol Clin Immunol 1999;9:361-366.
37. Reiss TF, Hill JB, Harman E, Zhang J, Tanaka WK, Bronsky E, Guerreiro D, Hendeles L. Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist. Thorax 1997;52:1030-1035.
38. Becker A. Leukotriene receptor antagonists: efficacy and safety in children with asthma. Pediatr Pulmonol 2000;30:183-186.